I think the list also shows that an NIH grant is a realistic goal. It's not like EU Horizon Europe grants that only go to big consortia with top institutions from multiple different countries involved. Avik Roy got funding for a speculative mouse model with only some very preliminary data and he...
Made a summary blog post here:
https://mecfsskeptic.com/nih-funding-for-me-cfs-in-2024/
Social media summaries:
https://bsky.app/profile/mecfsskeptic.bsky.social/post/3lbmkj6ux632t
There is a NIH funded trial for Gulf War illness that will test this:
Microbiome targeted oral butyrate therapy in Gulf War multisymptom illness
The goal of this clinical trial is to determine if a Butyrate formulation that consists of butyric acid as calcium and magnesium derivatives in a...
I've tried to make an overview of ME/CFS studies that received NIH funding in 2024. I've only included studies whose primary focus is ME/CFS - it's likely that ME/CFS is included in other projects such as those on Long Covid or other related conditions.
EDIT: This post has been updated. I...
Markku Partinen was an author of this ME/CFS paper:
https://www.s4me.info/threads/a-qualitative-longitudinal-study-of-a-health-psychological-group-intervention-for-patients-with-me-cfs-2023-keurulainen-et-al.34562/#post-487155
Hoping that they make the data public so that others can analyze it.
Is this all that they report: not even an effect size or table of the main findings?
Because of the selection criteria, the patient groups already had orthostatic tachycardia or reduced cerebral perfusion. So I suppose the main finding is that these patient groups have only relatively mild autonomic dysfunction in other domains.
The discussion also includes some speculation...
In comparison here's a 2019 study that used G93.3 codes from the US Optum database which I think looks less reliable than the Norwegian data.
https://pubmed.ncbi.nlm.nih.gov/30671425/
Prevalence of ME (G93.3) was 120 (actual data) - 870 (extrapolated) per 100.000. Female predominance of 60%...
It all depends however on how reliable those databases are.
- First there is the question of whether the diagnostic code G93.3 really reflects ME/CFS. In past database-studies of this kind we have seen abnormally high prevalence rates that increase in older age groups. Table 4 suggests that...
Looks very interesting. Impressed by the work of Kielland so far.
Some take-away points:
- At the time of diagnosis most of the decline in income (and increase in sick leave benefits and transfers) already occurred. If you look at those years before diagnosis, the effect looks really strong...
Indeed, quite sad. I wonder if it's mainly the name 'chronic fatigue syndrome' that has made questionnaire research like this unreliable and if it's the respondents themselves who are confusing chronic fatigue with CFS or doctors.
The EMEA survey said that the average age of respondents was 50 years with the following distribution:
https://europeanmealliance.org/emea-pan-european-survey-uk.shtml
These look slightly younger but the age peak is also between 40 and 60. The EMEA survey was conducted online while the NHIS...
Noticed that the data of these NHIS surveys is open-access and available here:
https://www.cdc.gov/nchs/nhis/data-questionnaires-documentation.htm
Had a quick look at the most recent data from 2023 (more recent than the Unger paper posted here).
Summary 2023 NHIS survey
29522 adults...
The 14 projects funded by the ZonMw Long Covid program in the Netherlands has been published. It looks quite impressive. The total budget has been increased from 6 to 11.4 miljoen euros.
https://www.zonmw.nl/nl/nieuws/honorering-van-projecten-biomedische-en-klinische-rondes-post-covid
On page 41, the document itself says 61 treatment withdrawals for FITNET compared to 12 for AM. Not sure what the difference with the flow chart comes from.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.